Top Markets
Coin of the day
Fusion Antibodies plc Fusion Antibodies plc

Fusion Antibodies plc

FAB
주식 순위 #40225
Fusion Antibodies plc operates as a contract research organization (CRO),... Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
주가
$0.1559364
마지막 동기화: 2026-09-18
시가총액
$195.17K
변동 (1일)
6.60%
변동 (1년)
-30.91%
국가
GB
거래 Fusion Antibodies plc (FAB)

카테고리

Fusion Antibodies plc (FAB)의 주가 이력
최고 종가: $0.15 (2026-09-01 기준)

최저 종가: $2.40 (2017-12-01 기준)
Fusion Antibodies plc의 주가 이력 (2017 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -10.83%
2025 153.72%
2024 39.11%
2023 -88.99%
2022 -66.99%
2021 -1.91%
2020 55.79%
2019 51.91%
2018 -71.85%
2017 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$509.53 32.99%
US
$991.92 34.63%
NL
$154.28 511.26%
US
$123.40 -5.68%
AU
$708.28 3.70%
CH